1-5 of 5
Margaret K. Yu
Close
Sort by
Journal Articles

Up-Regulation of miR-195 Expression Leads to Decreased Expression of Basic Fibroblast Growth Factor in CLL Patients Treated with DNA Methylation Inhibitors.

John D. Phillips, PhD, Ioana Pop, MS, Ken Boucher, PhD, Margaret K. Yu, MD
Journal: Blood
Blood (2007) 110 (11): 3183.
https://doi.org/10.1182/blood.V110.11.3183.3183
Published: 2007
Journal Articles

Upregulation of SOCS-1 and Downregulation of miR-214 Correlate with Disease Course in Chronic Lymphocytic Leukemia.

Kimberly A. Jones, MD, John D. Phillips, PhD, Joshua T. Mendell, MD,PhD, Martha G. Glenn, MD, Margaret K. Yu, MD
Journal: Blood
Blood (2006) 108 (11): 4313.
https://doi.org/10.1182/blood.V108.11.4313.4313
Published: 2006
Journal Articles

DNA Methylation Inhibitors Upregulate MiRNA Expression in Patients with Chronic Lymphocytic Leukemia.

Margaret K. Yu, MD, Joshua T. Mendell, MD,PhD, Martha G. Glenn, MD, Zhong Chen, MD, Kimberly A. Jones, MD, John D. Phillips, PhD
Journal: Blood
Blood (2006) 108 (11): 2257.
https://doi.org/10.1182/blood.V108.11.2257.2257
Published: 2006
Journal Articles

Global DNA Hypermethylation in Chronic Lymphocytic Leukemia Correlates with Progressive Disease.

Margaret K. Yu, MD, Aniko Szabo, PhD, Hector Bergonia, Anna Senina, John D. Phillips, PhD
Journal: Blood
Blood (2005) 106 (11): 5006.
https://doi.org/10.1182/blood.V106.11.5006.5006
Published: 2005
Journal Articles

Is Cladribine, a Treatment for Chronic Lymphocytic Leukemia, a DNA Methylation Inhibitor?.

Margaret K. Yu, Mark Wade, Brent C. Moore, Frank A. Fitzpatrick
Journal: Blood
Blood (2004) 104 (11): 4770.
https://doi.org/10.1182/blood.V104.11.4770.4770
Published: 2004